ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Investigating feature-engineered predictors for systolic blood pressure changes in an mHealth-based disease management program.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mobile health (mHealth)-based disease management programs enable continuous monitoring of blood pressure (BP) and related health behaviors. Feature engineering may help to extract informative predictors from longitudinal data, potentially improving BP change prediction. This study aimed to evaluate whether feature-engineered predictors can improve the prediction of systolic BP (SBP) changes using an mHealth-based disease management program. We analyzed data from participants with hypertension, dyslipidemia, or diabetes mellitus who completed the 24-week Mystar program, which combined phone-based coaching, remote monitoring, and app-based logging of BP and behavioral data. The primary outcome was the change in morning SBP from baseline to the end of the program. Prediction models for SBP changes were developed using ElasticNet regression at weeks 4, 8, 12, and 22 by comparing models with and without feature-engineered variables generated by feature tools. In total, 2318 participants were included in the analysis. At week 4, the top feature after feature engineering showed a stronger correlation with SBP change (r = 0.561) than the best original predictor (r = 0.455), although the model-level performance was similar (r = 0.561 vs. 0.559). By week 22, both models achieved a high correlation of approximately 0.85 with no substantial difference in performance. Feature engineering increased the correlation between individual predictors and SBP change in the early phase; however, the overall prediction performance of the ElasticNet model remained largely unchanged. Further studies are required to confirm these findings and examine their applicability in broader clinical and implementation contexts. Data from a 24-week mHealth-based program were analyzed to predict systolic blood pressure SBP changes using feature-engineered variables and ElasticNet regression. In the early phase, feature-engineered predictors ranked highest in importance, although overall model performance remained similar with and without feature engineering. Prediction accuracy improved over time, with correlations reaching ~0.85 by week 22.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.